The Medicines and Healthcare Products Regulatory Agency (MHRA) has launched ‘ground-breaking’ new datasets to help develop medical technologies.
Real-world data were used as a starting point, and then simulations have produced realistic information for researchers to work with.
“Synthetic datasets like these are valuable in the development and testing of machine learning and artificial intelligence (AI) algorithms in medical devices used for diagnosing diseases and monitoring and improving health conditions…
“The datasets were produced by a collaboration between the Clinical Practice Research Datalink (CPRD), MHRA Medical Devices Division and researchers at Brunel University.”
It is intended that the first uses of the datasets will be in development of products to combat COVID-19 and cardiovascular disease.
Read the MHRA press release to find out more about accessing the datasets and the methodology used to create them.